Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Financials
Manufacturing
Ansa snares $54.4M in series B to boost its DNA synthesis tech
Ansa Biotechnologies hauled in $54.4 million in a series B financing round that will be used to expand DNA synthesis capacity.
Joseph Keenan
Oct 2, 2025 8:50am
Trump administration teases MFN drug pricing rule
Sep 26, 2025 11:32am
Sponsored
BioNTech's African mRNA production push gets EU funding boost
Oct 14, 2025 9:20am
Trump carves out generics from US-Japan trade deal
Sep 8, 2025 11:50am
UK pharma drug price talks reach impasse
Aug 22, 2025 10:50am
Sarepta extends $700M debt to 2030 amid Elevidys uncertainty
Aug 21, 2025 10:52am
